These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Slow prepubertal linear growth but early pubertal growth spurt in patients with shunted hydrocephalus. Löppönen T; Saukkonen AL; Serlo W; Lanning P; Knip M Pediatrics; 1995 Jun; 95(6):917-23. PubMed ID: 7761221 [TBL] [Abstract][Full Text] [Related]
4. Incidence of short stature in children with hydrocephalus. Klauschie J; Rose SR J Pediatr Endocrinol Metab; 1996; 9(2):181-7. PubMed ID: 8887141 [TBL] [Abstract][Full Text] [Related]
5. Intellectual functioning in children with early shunted posthemorrhagic hydrocephalus. Lacy M; Pyykkonen BA; Hunter SJ; Do T; Oliveira M; Austria E; Mottlow D; Larson E; Frim D Pediatr Neurosurg; 2008; 44(5):376-81. PubMed ID: 18703883 [TBL] [Abstract][Full Text] [Related]
6. CSF shunt removal in children with hydrocephalus. Iannelli A; Rea G; Di Rocco C Acta Neurochir (Wien); 2005 May; 147(5):503-7; discussion 507. PubMed ID: 15838593 [TBL] [Abstract][Full Text] [Related]
7. Headaches in patients with shunts. Rekate HL; Kranz D Semin Pediatr Neurol; 2009 Mar; 16(1):27-30. PubMed ID: 19410154 [TBL] [Abstract][Full Text] [Related]
8. Morbidity and outcome of shunted hydrocephalus. Pople IK; Quinn MW; Bayston R Z Kinderchir; 1990 Dec; 45 Suppl 1():29-31. PubMed ID: 2293533 [TBL] [Abstract][Full Text] [Related]
9. Endocrinological disorders in shunted hydrocephalus. Kaiser G; Ruedeberg A; Arnold M Z Kinderchir; 1989 Dec; 44 Suppl 1():16-7. PubMed ID: 2623957 [TBL] [Abstract][Full Text] [Related]
10. Chronic headaches in adults with spina bifida and associated hydrocephalus. Edwards RJ; Witchell C; Pople IK Eur J Pediatr Surg; 2003 Dec; 13 Suppl 1():S13-7. PubMed ID: 14758561 [TBL] [Abstract][Full Text] [Related]
11. The programmable adult Codman Hakim valve is useful even in very small children with hydrocephalus. A 7-year retrospective study with special focus on cost/benefit analysis. Arnell K; Eriksson E; Olsen L Eur J Pediatr Surg; 2006 Feb; 16(1):1-7. PubMed ID: 16544218 [TBL] [Abstract][Full Text] [Related]
12. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498 [TBL] [Abstract][Full Text] [Related]
13. Complications of endoscopic third ventriculostomy in previously shunted patients. Hader WJ; Walker RL; Myles ST; Hamilton M Neurosurgery; 2008 Jul; 63(1 Suppl 1):ONS168-74; discussion ONS174-5. PubMed ID: 18728596 [TBL] [Abstract][Full Text] [Related]
14. Outcome of ventriculoperitoneal shunt placement in Grade IV tubercular meningitis with hydrocephalus: a retrospective analysis in 95 patients. Clinical article. Srikantha U; Morab JV; Sastry S; Abraham R; Balasubramaniam A; Somanna S; Devi I; Bangalore CA; Pandey P J Neurosurg Pediatr; 2009 Aug; 4(2):176-83. PubMed ID: 19645554 [TBL] [Abstract][Full Text] [Related]
15. CSF outflow resistance as predictor of shunt function. A long-term study. Malm J; Lundkvist B; Eklund A; Koskinen LO; Kristensen B Acta Neurol Scand; 2004 Sep; 110(3):154-60. PubMed ID: 15285771 [TBL] [Abstract][Full Text] [Related]
16. Monte Carlo simulation of cerebrospinal fluid shunt failure and definition of instability among shunt-treated patients with hydrocephalus. Piatt JH; Cosgriff M J Neurosurg; 2007 Dec; 107(6 Suppl):474-8. PubMed ID: 18154016 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of endoscopic third ventriculostomy in obstructive hydrocephalus. Gangemi M; Mascari C; Maiuri F; Godano U; Donati P; Longatti PL Minim Invasive Neurosurg; 2007 Oct; 50(5):265-9. PubMed ID: 18058641 [TBL] [Abstract][Full Text] [Related]
19. [Pregnancy and delivery in women with cerebrospinal fluid shunt due to hydrocephalus]. Nikolov A; Surchev Zh; Nalbanski B; Diavolov V; Dimitrov A Akush Ginekol (Sofiia); 2008; 47(2):3-10. PubMed ID: 18642578 [TBL] [Abstract][Full Text] [Related]
20. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole. Almeida MQ; Brito VN; Lins TS; Guerra-Junior G; de Castro M; Antonini SR; Arnhold IJ; Mendonca BB; Latronico AC Clin Endocrinol (Oxf); 2008 Jul; 69(1):93-8. PubMed ID: 18088394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]